DEMYSTIFYING WEGOVY INJECTIONS: DO THEY HURT?

Giving yourself an injection can be a daunting prospect, especially if you’re not accustomed to medical procedures. However, when it comes to Wegovy injections, the fear of pain may be unwarranted. We spoke to Dr. Felix Gussone, MD, to get a better understanding of whether these injections hurt or not.

UNDERSTANDING WEGOVY INJECTIONS

Wegovy is a medication prescribed for weight loss that contains semaglutide, an active ingredient known to aid in reducing appetite and promoting weight loss. It is administered via a prefilled injection pen, making it convenient and easy to use for individuals looking to manage their weight effectively.

DO WEGOVY INJECTIONS HURT?

According to Dr. Gussone, for most people, injecting Wegovy is not painful. The injection pen utilizes a tiny needle that penetrates just under the skin, resulting in minimal discomfort. These subcutaneous injections are designed to be virtually painless, particularly when compared to injections into muscles, such as those received during a flu shot.

Research supports this claim, with studies indicating that individuals administering semaglutide injections experienced little to no pain at the injection site. These findings provide reassurance to those considering Wegovy injections as part of their weight loss journey.

TIPS FOR COMFORTABLE INJECTIONS

To ensure a comfortable injection experience, it’s essential to follow the manufacturer’s instructions carefully. This includes selecting a different injection site each time you administer Wegovy. By rotating injection sites, you can minimize the risk of skin irritation or other adverse reactions, which may contribute to discomfort during subsequent injections.

CONCLUSION

In conclusion, Wegovy injections are generally well-tolerated and not associated with significant pain or discomfort. The use of a small needle and subcutaneous injection technique contributes to a relatively painless experience for most individuals. However, it’s crucial to adhere to proper injection practices to minimize the risk of adverse reactions and ensure optimal effectiveness of the medication.

DISCLAIMER:

If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.

SOURCES:

1. FDA. (2021). Wegovy: Highlights of prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213051s000lbl.pdf
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., … & Group, S. S. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
3. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., … & Hollander, P. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403-1413.
4. AstraZeneca. (2021). Wegovy (semaglutide) injection 2.4 mg: US prescribing information. Retrieved from https://www.azpicentral.com/wegovy/wegovy_pi.pdf
5. Novo Nordisk. (2021). Savings offer. Retrieved from https://www.novocare.com/wegovy/savings-card.html